PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.66%
Revenue growth above 1.5x 6247.T's 22.59%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
59.90%
Gross profit growth above 1.5x 6247.T's 20.84%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
246.35%
EBIT growth below 50% of 6247.T's 1988.79%. Michael Burry would suspect deeper competitive or cost structure issues.
278.29%
Operating income growth at 50-75% of 6247.T's 387.13%. Martin Whitman would doubt the firm’s ability to compete efficiently.
273.35%
Net income growth under 50% of 6247.T's 1922.03%. Michael Burry would suspect the firm is falling well behind a key competitor.
270.85%
EPS growth under 50% of 6247.T's 1923.36%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
270.85%
Diluted EPS growth under 50% of 6247.T's 1923.36%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.31%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-12.24%
Negative 5Y CAGR while 6247.T stands at 21.18%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
36.30%
3Y revenue/share CAGR above 1.5x 6247.T's 0.21%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
105.45%
Net income/share CAGR at 50-75% of 6247.T's 172.40%. Martin Whitman might question if the firm’s product or cost base lags behind.
-18.35%
Negative 5Y net income/share CAGR while 6247.T is 1946.15%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
212.69%
3Y net income/share CAGR similar to 6247.T's 221.53%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-67.71%
Negative equity/share CAGR over 10 years while 6247.T stands at 28.45%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
152.79%
5Y equity/share CAGR above 1.5x 6247.T's 22.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
17.38%
3Y equity/share CAGR 1.25-1.5x 6247.T's 13.03%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.05%
Firm’s AR is declining while 6247.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-27.64%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-16.98%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
4.53%
Positive BV/share change while 6247.T is negative. John Neff sees a clear edge over a competitor losing equity.
-48.16%
We’re deleveraging while 6247.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-34.40%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.